Alkermes | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

25 March 2025

Mural fails to paint a convincing picture for nemvaleukin

The Artistry-7 Keytruda combo trial fails, spurring discontinuation in ovarian cancer.

Subscribe to Alkermes